BriaCell Therapeutics Corp.
AI Valuation
AI-generated fair value estimate for this company.
AI Fair Value
$1.07
Market Price
$0.90
Undervalued By
16.1%
Method: Current traded market price of the BriaCell Therapeutics warrant expiring 2031 (BCTXL), $1.065, issued alongside the January 2026 $30 million public offering priced at $5.59 per unit; BriaCell common (BCTX) itself trades at $4.09.
Reasoning: Given BriaCell's extreme historical volatility (52-week range $2.60-$14.68) driven by binary Phase 3 breast-cancer trial catalysts for lead candidate Bria-IMT, the observed market price for this modestly out-of-the-money, multi-year warrant is a more reliable fair-value estimate than a model relying on assumed volatility inputs.